Anna Gluskin
Directeur/Bestuurslid bij EASTGATE BIOTECH CORP.
Actieve functies van Anna Gluskin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
EASTGATE BIOTECH CORP. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | 22-05-2012 | - | |
Voorzitter | 22-05-2012 | - | |
Eastgate Pharmaceuticals, Inc.
Eastgate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eastgate Pharmaceuticals, Inc. operates as a pharmaceutical research and product company. The company is headquartered in North York, Canada. | Algemeen Directeur | 01-03-2011 | - |
Loopbaan van Anna Gluskin
Eerdere bekende functies van Anna Gluskin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NUGENEREX IMMUNO-ONCOLOGY, INC. | Directeur/Bestuurslid | 14-01-2011 | 14-01-2011 |
Generex Pharmaceuticals, Inc.
Generex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Generex Biotechnology Corp., Generex Pharmaceuticals, Inc. provides pharmaceutical products. The company is based in Toronto, Canada. | Directeur/Bestuurslid | 14-01-2011 | 14-01-2011 |
PROTECT PHARMACEUTICAL CORPORATION | Directeur/Bestuurslid | 02-07-2010 | 01-09-2010 |
GENEREX BIOTECHNOLOGY CORPORATION | Algemeen Directeur | 01-11-1995 | 01-09-2010 |
Oprichter | 01-11-1995 | 01-09-2010 | |
President | 01-11-1995 | 01-09-2010 | |
Interlock Consolidated Enterprises, Inc. | Directeur/Bestuurslid | - | - |
Opleiding van Anna Gluskin
Moscow State University Lomonosov | Graduate Degree |
University of Toronto | Graduate Degree |
Statistieken
Internationaal
Canada | 6 |
Verenigde Staten | 4 |
Rusland | 2 |
Operationeel
Director/Board Member | 5 |
Chief Executive Officer | 3 |
Graduate Degree | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Transportation | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PROTECT PHARMACEUTICAL CORPORATION | Transportation |
EASTGATE BIOTECH CORP. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Generex Pharmaceuticals, Inc.
Generex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Generex Biotechnology Corp., Generex Pharmaceuticals, Inc. provides pharmaceutical products. The company is based in Toronto, Canada. | Health Technology |
NuGenerex Immuno-Oncology, Inc.
NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL. | Health Technology |
Eastgate Pharmaceuticals, Inc.
Eastgate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eastgate Pharmaceuticals, Inc. operates as a pharmaceutical research and product company. The company is headquartered in North York, Canada. | Health Technology |
Interlock Consolidated Enterprises, Inc. | |
Generex Biotechnology Corp.
Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
- Beurs
- Insiders
- Anna Gluskin
- Ervaring